Imugene will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded more ‘complete responses’ in its phase 1b study.

Imugene will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded more &lsquo;complete responses&rsquo; in its phase 1b study.

Money News — the most respected business program on radio.

If you crave the latest insights into super & small business, interest rates & investment, and economics & e-commerce, then the team at Money News has everything you need to know.

Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing moneynews@2gb.com

Money News &mdash; the most respected business program on radio.
If you crave the latest insights into super &amp; small business, interest rates &amp; investment, and economics &amp; e-commerce, then the team at Money News has everything you need to know.
Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing <a href="mailto:moneynews@2gb.com">moneynews@2gb.com</a>